COBRE-PSF member and KU Pharmacology and Toxicology faculty member Jeff Staudinger has been promoted from associate to full professor at The University of Kansas. He was among those for whom the Kansas Board of Regents approved promotions and appointments of tenure at Kansas universities in April 2013.
Staudinger earned a B.S. in biology in 1987 from Nebraska Wesleyan University, Lincoln, NE, and an M.S. (1994) and Ph.D. (1996) in biochemistry and molecular biology from the University of Texas Graduate School of Biomedical Sciences, Houston, TX. He completed a research fellowship (1996-1999) in the Nuclear Receptor Group at GlaxoWellcome, Research Triangle Park, NC and a research fellowship in the Department of Pharmacology and Toxicology at KU (1999-2001) before joining the faculty as an assistant professor in 2001. Staudinger was funded as a research investigator by the COBRE-PSF from 2002-2005 and has served on the Center's Internal Advisory Committee since 2008.
Staudinger and his research group are interested in basic regulatory mechanisms in toxicology and drug disposition. They work primarily with mice and tissue culture as model systems to investigate two major questions. (1) What role do hepatic ligand-activated transcription factors play in regulating drug disposition, and (2) How do alterations in either nutritional- or health-status impact drug disposition.